Pediatrix Medical Group, Inc. (MD) Insider Trading
Insiders sold $1.83M and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Director Shirley A Weis sold $856k on May 13, 66% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2019.
Get an email when MD's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| May 13 | Shirley A Weis Director | SoldNo plan | 36,028 | $23.75 | $856k | 66% | Form 4 |
| Dec 15, 2025 | Mark S Ordan Chief Executive Officer | SoldNo plan | 23,000 | $22.41 | $515k | 7.1% | Form 4 |
| Nov 17, 2025 | Michael A. Rucker Director | SoldNo plan | 10,478 | $23.00 | $241k | 15% | Form 4 |
| Nov 6, 2025 | Laura A Linynsky Director | SoldNo plan | 10,000 | $21.65 | $217k | 24% | Form 4 |
| Nov 13, 2024 | Mark S Ordan Director | SoldNo plan | 27,600 | $15.35 | $424k | 17% | Form 4 |
| Nov 8, 2024 | Mary Ann E Moore EVP, GC, Chief Admin Off & Sec | SoldNo plan | 8,108 | $16.00 | $130k | 5.1% | Form 4 |
- May 13No planShirley A WeisDirector · sold 36,028 at $23.75$856k66% of stake
- Dec 15, 2025No planMark S OrdanChief Executive Officer · sold 23,000 at $22.41$515k7.1% of stake
- Nov 17, 2025No planMichael A. RuckerDirector · sold 10,478 at $23.00$241k15% of stake
- Nov 6, 2025No planLaura A LinynskyDirector · sold 10,000 at $21.65$217k24% of stake
- Nov 13, 2024No planMark S OrdanDirector · sold 27,600 at $15.35$424k17% of stake
- Nov 8, 2024No planMary Ann E MooreEVP, GC, Chief Admin Off & Sec · sold 8,108 at $16.00$130k5.1% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Services-Hospitals
Spot a number that looks wrong? Check it in MD's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing MD
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.